QOL to be completed by the participant
OtherThe scales (PUTS, OCI, TS-QOL, ASRS, GAD-7, PHQ9, TAPS) to be completed by the participant
NCT Number: NCT05090943
The purpose of this study is to develop the adult tic disorders registry in order to characterize the relationship between tic severity and tic-related impairment in women compared to men with tic disorders.
Interested in participating?
Request Info18 year and older
All sexes
Observational
CHU Clermont-Ferrand, Clermont-Ferrand, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Non Inclusion criteria
The scales (PUTS, OCI, TS-QOL, ASRS, GAD-7, PHQ9, TAPS) to be completed by the participant
Time frame: 6 months
Severity of the tics measurement (YGTSS Impairment Score) and the quality of life (TS-QOL) between men and women with tic disorders, while controlling for the YGTSS Total Tic Score
Time frame: 6 months
Change in tic inventories/tic migrations with the YGTSS tic inventories
Contact information is provided by the study sponsor or research team.
Assistance Publique - Hôpitaux de Paris
Other
Acronym: RegisTICs
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07725926
Anxiety Disorders, Basal Ganglia Diseases
London, United Kingdom
View Trial DetailsNCT06081348
22Q11 Deletion, 22q11 Deletion Syndrome
Calgary, Alberta, Canada
View Trial DetailsNCT06679790
Basal Ganglia Diseases, Brain Diseases
Minneapolis, Minnesota, United States
View Trial DetailsNCT06408662
Basal Ganglia Diseases, Brain Diseases
Baltimore, Maryland, United States
View Trial Details